Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16074730 | 0.92 | GPR84 (0.41) | CA2FDPSGPR84 | |
| SCHEMBL6053227 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074898 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074907 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074853 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074883 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074930 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074728 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL5898206 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 | |
| SCHEMBL16074921 | 0.90 | GPR84 (0.45) | CA2FDPSGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539853-A1 | HUMORAL IMMUNE ACTIVATORS FOR THE TREATMENT OF HUMORAL IMMUNOSUPPRESSED PATHOLOGIES, CANCER AND INFECTIOUS DISEASE AND HUMORAL IMMUNE SUPPRESSORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Navrogen, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| CN-119768413-A | Amino sterol compounds, amino sterol-cyclodextrin formulations, and methods of using the same | 因特尔公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119677519-A | Humoral immune activators for the treatment of humoral immune-suppressive pathologies, cancers and infectious diseases and humoral immune inhibitors for the treatment of inflammatory diseases | 纳夫罗根公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118325562-A | Flame-retardant bi-component polyurethane pouring sealant and preparation method thereof | 广东德聚技术股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2023245086-A1 | HUMORAL IMMUNE ACTIVATORS FOR THE TREATMENT OF HUMORAL IMMUNOSUPPRESSED PATHOLOGIES, CANCER AND INFECTIOUS DISEASE AND HUMORAL IMMUNE SUPPRESSORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Navrogen, Inc. (US) | 2023-12-21 | — | — | WO | claimed |
| EP-4539853-A1 | HUMORAL IMMUNE ACTIVATORS FOR THE TREATMENT OF HUMORAL IMMUNOSUPPRESSED PATHOLOGIES, CANCER AND INFECTIOUS DISEASE AND HUMORAL IMMUNE SUPPRESSORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Navrogen, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119768413-A | Amino sterol compounds, amino sterol-cyclodextrin formulations, and methods of using the same | 因特尔公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119677519-A | Humoral immune activators for the treatment of humoral immune-suppressive pathologies, cancers and infectious diseases and humoral immune inhibitors for the treatment of inflammatory diseases | 纳夫罗根公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-118325562-A | Flame-retardant bi-component polyurethane pouring sealant and preparation method thereof | 广东德聚技术股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2023245086-A1 | HUMORAL IMMUNE ACTIVATORS FOR THE TREATMENT OF HUMORAL IMMUNOSUPPRESSED PATHOLOGIES, CANCER AND INFECTIOUS DISEASE AND HUMORAL IMMUNE SUPPRESSORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Navrogen, Inc. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023203904-A1 | TWO-PACK TYPE CURABLE POLYURETHANE RESIN COMPOSITION | 第一工業製薬株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023136064-A1 | TWO-COMPONENT CURABLE POLYURETHANE RESIN COMPOSITION | 第一工業製薬株式会社 | 2023-07-20 | — | — | WO | disclosed |
| WO-2008028097-A2 | METHOD FOR SKIN CARE | NULIV HOLDING INC. (TW) | 2008-03-06 | — | — | WO | disclosed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | disclosed |
| CN-1196082-A | Concentrated stable fabric softening compositions comprising chelants | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | disclosed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | disclosed |
| US-5747443-A | BIODEGRADABLE QUATERNARY AMMONIUM COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| US-5444170-A | Using cocatalyst system comprising palladium and platinum; prevents catalyst poisoning | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1995-08-22 | — | — | US | disclosed |